News & Blog
Optimising the Epidermis for Enhanced Results
07/05/2025 • by The RAM Institute
Aesthetician Liliana Lucianelli explores how non-invasive hydradermabrasion and skin conditioning strategies can support tissue readiness, treatment response and long-term maintenance when integrated with regenerative procedures
Over the past decade, the field of skin care has undergone a significant transformation, moving away from purely cosmetic approaches toward treatments designed to support skin physiology, barrier function, and cellular regeneration. Within regenerative aesthetic medicine, increasing attention is being paid to the role of the epidermis not simply as a surface layer, but as an active biological interface that influences treatment response, recovery, and long‑term skin quality.
Within this evolving landscape, non‑invasive epidermal optimisation treatments have become an integral component of modern aesthetic practice, particularly when used alongside regenerative and biostimulatory procedures.
As an aesthetician and beauty advisor at Balance Clinic in Milan, where I work in close collaboration with Dr Pierluigi Gigliofiorito in the management of integrated aesthetic pathways, I have observed how structured skin conditioning and maintenance protocols can support the outcomes of medical aesthetic treatments.
When appropriately selected, device‑based hydradermabrasion treatments can function as supportive tools for preparing the skin prior to regenerative interventions and for maintaining skin health over time.
Epidermal optimisation and regenerative aesthetic practice
Regenerative aesthetic medicine increasingly focuses on improving tissue quality, cellular signalling, and biological resilience rather than addressing isolated surface concerns. While many regenerative treatments act primarily within the dermis or deeper tissue planes, their effectiveness is influenced by the condition of the epidermis, barrier function, and inflammatory load at the skin surface.1-4
Epidermal optimisation strategies aim to support these factors through controlled exfoliation, hydration, and topical delivery of bioactive substances, without inducing tissue injury or inflammatory disruption. Within this context, treatments such as hydradermabrasion represent one approach to non-ablative skin conditioning rather than a standalone aesthetic solution.5-8
The role of hydradermabrasion treatments
Hydradermabrasion refers to a category of non-invasive epidermal treatments that combine controlled exfoliation, cleansing, extraction of surface impurities, and topical infusion of active substances within a single session. These treatments are designed to improve epidermal function and skin quality without inducing tissue injury or provoking significant inflammatory responses.
From a biological perspective, hydradermabrasion aims to reduce corneocyte build-up, surface congestion, and environmental burden while supporting hydration and barrier homeostasis. Unlike ablative or aggressive resurfacing techniques, this approach preserves epidermal integrity and avoids the creation of micro-lesions, making it particularly suitable for integration alongside regenerative and injectable procedures.9-11
Simultaneously, the skin is exposed to topical formulations containing humectants, antioxidants, peptides, and calming agents. While penetration remains primarily superficial, improved surface conditions and hydration may enhance epidermal-dermal signalling and patient tolerance of subsequent regenerative treatments.12-14
A typical session lasts between 30 and 45 minutes and requires no downtime, allowing patients to resume daily activities immediately. This non-disruptive profile underpins the use of hydradermabrasion as a preparatory or maintenance strategy within regenerative treatment pathways.
In my own clinical practice, I use HydraFacial as a hydradermabrasion platform due to its reproducibility, safety profile, and adaptability within multidisciplinary treatment plans. Its value lies not in replacing regenerative interventions, but in supporting skin conditioning and long-term maintenance when used with appropriate clinical judgement.
Biological rationale for use alongside regenerative treatments
One of the most clinically relevant effects is reduction of surface congestion and inflammatory burden. By facilitating removal of excess sebum, keratin debris, and environmental pollutants, these treatments may contribute to a more stable epidermal environment prior to regenerative intervention.15-17
Another key factor is hydration. Adequate epidermal hydration supports barrier function, optimises trans-epidermal signalling, and may improve patient tolerance and recovery following injectable or device-based regenerative procedures. The infusion of hyaluronic acid and humectant substances helps restore hydrolipid balance, resulting in skin that appears more elastic and resilient.18-21
From a regenerative perspective, controlled exfoliation may also support more uniform cellular turnover without triggering inflammatory cascades. This is particularly relevant when planning treatments that rely on fibroblast activation, neocollagenesis, or tissue remodelling, such as biostimulatory injectables or polynucleotide-based therapies.22-24
Integration with regenerative and injectable treatments
The value of hydradermabrasion becomes most apparent when incorporated into a structured aesthetic medicine programme rather than used in isolation. At Balance Clinic, epidermal optimisation treatments are integrated alongside regenerative procedures including dermal fillers, botulinum toxin, biostimulation, microneedling, and selected chemical peel protocols.
In preparation for regenerative injectables, such treatments may be used to improve hydration, reduce superficial congestion, and support overall skin quality prior to intervention. This allows the physician to work within a more balanced tissue environment, potentially contributing to more predictable and harmonious outcomes.
Following injectable treatments, timing is critical. Epidermal treatments involving suction or manipulation are typically postponed for one to two weeks, depending on the procedure performed and individual tissue response, to avoid interference with product integration or healing processes.
When used alongside microneedling or controlled chemical exfoliation, hydradermabrasion treatments are more commonly positioned within maintenance or recovery phases, where the focus shifts toward calming the skin, restoring hydration, and supporting barrier recovery.
Protocol design and clinical judgement
The integration of epidermal optimisation treatments within regenerative aesthetic medicine relies on personalised protocols and close interdisciplinary collaboration.
Treatment timing, frequency, and topical formulation selection must be adapted to the patient’s skin condition, treatment history, and regenerative objectives. These treatments should not be applied routinely or automatically, but rather incorporated based on clear clinical rationale.
The role of the aesthetician is central in this process, particularly in ongoing skin monitoring, protocol adjustment, and communication with the medical practitioner. This collaborative model ensures that epidermal treatments support, rather than compete with, regenerative strategies.
Personalisation and booster selection
Personalisation remains essential within epidermal optimisation protocols. Within the context of HydraFacial treatments, this is primarily achieved through the selection of targeted booster serums, which are incorporated during the hydradermabrasion process to address specific skin priorities.
Depending on individual skin presentation, boosters may be selected to support hydration, address oxidative stress, improve barrier function, or target early signs of ageing. These formulations typically contain combinations of humectants, antioxidants, peptides, and other bioactive compounds designed for superficial epidermal delivery.
Within a regenerative framework, the role of HydraFacial boosters is not to drive biological change independently, but to support skin conditioning, comfort, and resilience, particularly when treatments are being delivered alongside injectable or device-based regenerative procedures.
In this context, personalisation through booster selection allows the aesthetician to fine-tune epidermal support while remaining aligned with the broader regenerative treatment plan established by the medical practitioner.
Indications and precautions
Despite a favourable safety profile, epidermal hydradermabrasion treatments require careful patient assessment. Active dermatitis, cutaneous infection, recent sunburn, or acute inflammatory skin conditions represent contraindications or indications for protocol modification, as epidermal manipulation may exacerbate inflammation or delay barrier recovery.25,26
Conclusion
Non-invasive epidermal optimisation treatments represent a valuable supportive component within contemporary regenerative aesthetic medicine. Evidence increasingly suggests that epidermal health, barrier function, and hydration status influence tissue response, recovery, and the longevity of regenerative outcomes.27-30
When integrated thoughtfully into personalised, multidisciplinary treatment pathways, hydradermabrasion treatments may contribute to improved skin conditioning, enhanced recovery, and maintenance of regenerative results over time. Rather than functioning as standalone aesthetic solutions, such treatments are best understood as modulators of the skin environment that support biological processes initiated by regenerative and injectable interventions.
Disclaimer: This article discusses hydradermabrasion treatments within the context of regenerative aesthetic medicine. Specific technologies are referenced as illustrative examples based on clinical experience rather than as endorsements. Treatment selection, sequencing, and protocol design should always be guided by individual patient assessment, practitioner expertise, and current evidence-based guidelines.
Comment from Dr Pierluigi Gigliofiorito
Hydradermbrasion represents a strategic support for regenerative procedures such as fillers as it improves skin tissue quality by creating an optimal biological environment for the integration and effectiveness of injectable treatments through deep cleansing controlled exfoliation and intensive hydration which promote oxygenation elasticity and barrier function while reducing oxidative stress and cutaneous inflammation thereby contributing to more harmonious long lasting results and improved post procedure recovery.
References
- Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermatoendocrinol. 2012;4(3):308–319.
- Rittié L, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Res Rev. 2002;1(4):705–720.
- Kammeyer A, Luiten RM. Oxidation events and skin aging. Ageing Res Rev. 2015;21:16–29.
- Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. The skin aging exposome. J Dermatol Sci. 2017;85(3):152–161.
- Voegeli R. The role of corneocyte cohesion in the barrier function of the stratum corneum. Dermatol Ther. 2004;17(Suppl 1):5–12.
- Draelos ZD. The science behind skin care: moisturizers. J Cosmet Dermatol. 2018;17(2):138–144.
- Berardesca E, Maibach H. Ethnic skin: overview of structure and function. J Am Acad Dermatol. 2003;48(6 Suppl):S139–S142.
- Harding CR, Watkinson A, Rawlings AV, Scott IR. Dry skin, moisturization and corneodesmolysis. Int J Cosmet Sci. 2000;22(1):21–52.
- Elias PM. Skin barrier function. Curr Allergy Asthma Rep. 2008;8(4):299–305.
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072.
- Denda M, Tsutsumi M, Goto M, Ikeyama K, Denda S. Topical application of moisturizers prevents epidermal barrier disruption induced by mechanical stress. J Invest Dermatol. 2000;115(6):1059–1064.
- Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17(Suppl 1):43–48.
- Fluhr JW, Darlenski R, Taieb A, et al. Functional skin adaptation in infancy. Exp Dermatol. 2010;19(6):483–492.
- Lodén M. Effect of moisturizers on epidermal barrier function. Clin Dermatol. 2012;30(3):286–296.
- Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527–532.
- Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier. J Clin Aesthet Dermatol. 2013;6(3):18–24.
- Krutmann J, Liu W, Li L, et al. Pollution and skin: from epidemiological and mechanistic studies to clinical implications. J Dermatol Sci. 2014;76(3):163–168.
- Rawlings AV, Matts PJ. Stratum corneum moisturization at the molecular level. J Invest Dermatol. 2005;124(6):1099–1110.
- Fluhr JW, Gloor M, Lehmann L, et al. Glycerol accelerates recovery of barrier function in vivo. Br J Dermatol. 1999;140(6):1013–1020.
- Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253–258.
- Lodén M, Andersson AC, Andersson C, et al. Evaluation of glycerine and urea on dry skin. Skin Res Technol. 2001;7(4):209–213.
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462–1470.
- Quan T, Qin Z, Xia W, et al. Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc. 2009;14(1):20–24.
- Wang F, Garza LA, Kang S, et al. In vivo stimulation of collagen production following dermal filler injections. Arch Dermatol. 2007;143(2):155–163.
- Draelos ZD. Cosmetic Dermatology: Products and Procedures. 2nd ed. Oxford: Wiley-Blackwell; 2015. p. 79–92.
- Fluhr JW, Elias PM. Stratum corneum barrier function: relevance to topical dermatologic therapy. Dermatol Clin. 2007;25(2):155–168.
- Baumann L. Skin ageing and its treatment. J Pathol. 2007;211(2):241–251.
- Quan T, Fisher GJ. Role of age-associated alterations of the dermal extracellular matrix. Gerontology. 2015;61(5):427–434.
- Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of skin care products in the management of skin aging. Dermatology. 2011;223(1):1–14.
- Gold MH. Combination therapies in aesthetic medicine: synergy and sequencing. J Clin Aesthet Dermatol. 2014;7(9):13–20.








